151 related articles for article (PubMed ID: 37302527)
1. Characterization of alcohol-induced respiratory symptoms in aspirin-exacerbated respiratory disease.
Ramos CL; Thakrar H; Walters K; Waldram J; White AA
Ann Allergy Asthma Immunol; 2023 Sep; 131(3):382-384. PubMed ID: 37302527
[No Abstract] [Full Text] [Related]
2. Poor control of asthma symptoms with interleukin-5 inhibitors in four patients with aspirin-exacerbated respiratory disease.
Eid RC; Wudneh E; Zahid S; Cahill K; Jerschow E
Ann Allergy Asthma Immunol; 2020 Jan; 124(1):102-104. PubMed ID: 31605753
[No Abstract] [Full Text] [Related]
3. Aspirin-exacerbated respiratory disease: personalized medical and surgical approaches.
Schlosser RJ
Int Forum Allergy Rhinol; 2020 Sep; 10(9):1035-1036. PubMed ID: 32634286
[No Abstract] [Full Text] [Related]
4. Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease.
Pelletier T; Roizen G; Ren Z; Hudes G; Rosenstreich D; Jerschow E
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1319-1321. PubMed ID: 30144584
[No Abstract] [Full Text] [Related]
5. Immunologic effects of aspirin desensitization and high-dose aspirin therapy in aspirin-exacerbated respiratory disease.
Cahill KN
J Allergy Clin Immunol; 2021 Aug; 148(2):344-347. PubMed ID: 34144108
[No Abstract] [Full Text] [Related]
6. Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: A case series.
Martin H; Barrett NA; Laidlaw T
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1384-1385. PubMed ID: 32956852
[No Abstract] [Full Text] [Related]
7. Update on Aspirin-Exacerbated Respiratory Disease.
Woessner KM
Curr Allergy Asthma Rep; 2017 Jan; 17(1):2. PubMed ID: 28097500
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 in a series of patients with aspirin-exacerbated respiratory disease.
White AA; Cahill KN; Jerschow E; Kuruvilla M; Sehanobish E; Bensko J; Laidlaw TM; Levy JM
J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2900-2903. PubMed ID: 33965591
[No Abstract] [Full Text] [Related]
9. Diet may be the common factor linking aspirin-exacerbated respiratory disease and atherosclerotic cardiovascular disease.
Miller JD
J Allergy Clin Immunol Pract; 2024 Feb; 12(2):539-540. PubMed ID: 38336404
[No Abstract] [Full Text] [Related]
10. Aspirin-Exacerbated Respiratory Disease: The Hunt for the "Rosetta Stone" of Respiratory Inflammation.
White AA
Immunol Allergy Clin North Am; 2016 Nov; 36(4):xv-xvi. PubMed ID: 27712771
[No Abstract] [Full Text] [Related]
11. Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease.
Patel P; Bensko JC; Bhattacharyya N; Laidlaw TM; Buchheit KM
Ann Allergy Asthma Immunol; 2022 Mar; 128(3):326-328. PubMed ID: 34863953
[No Abstract] [Full Text] [Related]
12. Dupilumab increases aspirin tolerance in aspirin-exacerbated respiratory disease.
Mustafa SS; Vadamalai K
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):738-739. PubMed ID: 33746062
[No Abstract] [Full Text] [Related]
13. Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.
Buchheit KM; Hacker J; Maurer R; McGill A; Ryan T; Bensko JC; Laidlaw TM
Clin Exp Allergy; 2023 Sep; 53(9):974-977. PubMed ID: 37246613
[No Abstract] [Full Text] [Related]
14. Multidisciplinary single-center outcomes compared to two-center outcomes for the treatment of aspirin exacerbated respiratory disease.
Bosso JV; Tripathi SH; Kennedy DW; Kohanski MA; Cohen NA; Palmer JN; Adappa ND
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2498-2500. PubMed ID: 33548515
[No Abstract] [Full Text] [Related]
15. Accidental ingestion of aspirin and nonsteroidal anti-inflammatory drugs is common in patients with aspirin-exacerbated respiratory disease.
Kiladejo A; Palumbo M; Laidlaw TM
J Allergy Clin Immunol Pract; 2019; 7(5):1656-1658.e2. PubMed ID: 30481585
[No Abstract] [Full Text] [Related]
16. Type 2 biologics reduce cumulative steroid exposure in aspirin-exacerbated respiratory disease.
Ghiasi Y; Wangberg H; Bagsic SRS; White A
Ann Allergy Asthma Immunol; 2022 Nov; 129(5):642-643. PubMed ID: 35908738
[No Abstract] [Full Text] [Related]
17. Pediatric-onset aspirin-exacerbated respiratory disease: Clinical characteristics, prevalence, and response to dupilumab.
Bensko JC; McGill A; Palumbo M; Cahill KN; Laidlaw TM
J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2466-2468. PubMed ID: 35643277
[No Abstract] [Full Text] [Related]
18. Aspirin and salicylate in respiratory disease.
Mitchell JE; Skypala I
Rhinology; 2013 Sep; 51(3):195-205. PubMed ID: 23943725
[TBL] [Abstract][Full Text] [Related]
19. Objective validity of patient-reported symptoms in aspirin-exacerbated respiratory disease patients.
Patel PP; Cui J; Cahill KN; Laidlaw TM
Clin Exp Allergy; 2022 Feb; 52(2):348-351. PubMed ID: 34820927
[No Abstract] [Full Text] [Related]
20. Aspirin-Exacerbated Respiratory Disease.
White AA; Stevenson DD
N Engl J Med; 2018 Sep; 379(11):1060-1070. PubMed ID: 30207919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
